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Abstract 
Background: n-Butanol can serve as an excellent gasoline substitute. Naturally, it is produced by some Clostridia 
species which, however, exhibit only limited suitability for industrial n-butanol production. The yeast Saccharomyces 
cerevisiae would be an ideal host due to its high robustness in fermentation processes. Nevertheless, n-butanol yields 
and titers obtained so far with genetically engineered yeast strains are only low.
Results: In our recent work, we showed that n-butanol production via a clostridial acetoacetyl-CoA-derived pathway 
in engineered yeast was limited by the availability of coenzyme A (CoA) and cytosolic acetyl-CoA. Increasing their 
levels resulted in a strain producing up to 130 mg/L n-butanol under anaerobic conditions. Here, we show that under 
aerobic conditions. this strain can even produce up to 235 mg/L n-butanol probably due to a more efficient NADH re-
oxidation. Nevertheless, expression of a bacterial water-forming NADH oxidase (nox) significantly reduced n-butanol 
production although it showed a positive effect on growth and glucose consumption. Screening for an improved 
version of an acetyl-CoA forming NAD+-dependent acetylating acetaldehyde dehydrogenase, adhEA267T/E568K/R577S, 
and its integration into n-butanol-producing strain further improved n-butanol production. Moreover, deletion of the 
competing NADP+-dependent acetaldehyde dehydrogenase Ald6 had a superior effect on n-butanol formation. To 
increase the endogenous supply of CoA, amine oxidase Fms1 was overexpressed together with pantothenate kinase 
coaA from Escherichia coli, and could completely compensate the beneficial effect on n-butanol synthesis of addition 
of pantothenate to the medium. By overexpression of each of the enzymes of n-butanol pathway in the n-butanol-
producing yeast strain, it turned out that trans-2-enoyl-CoA reductase (ter) was limiting n-butanol production. Addi-
tional overexpression of ter finally resulted in a yeast strain producing n-butanol up to a titer of 0.86 g/L and a yield of 
0.071 g/g glucose.
Conclusions: By further optimizing substrate supply and redox power in the form of coenzyme A, acetyl-CoA and 
NADH, n-butanol production with engineered yeast cells could be improved to levels never reached before with S. 
cerevisiae via an acetoacetyl-CoA-derived pathway in synthetic medium. Moreover, our results indicate that the NAD+/
NADH redox balance and the trans-2-enoyl-CoA reductase reaction seem to be bottlenecks for n-butanol production 
with yeast.
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Background
Butanol isomers like n-butanol or isobutanol are 
regarded as more suitable fuel substitutes than bioetha-
nol. Butanol production via genetically engineered yeast 
cells has recently been reviewed in [1]. In our previous 
work, we have engineered the yeast Saccharomyces cer-
evisiae for n-butanol production via a Clostridia-derived 
acetoacetyl-CoA-dependent pathway [2] (Additional 
file  1: Figure S1). It turned out that the availability of 
coenzyme A (CoA) and cytosolic acetyl-CoA are limiting 
heterologous n-butanol production with yeast. For indus-
trial processes, the yeast S. cerevisiae is established as a 
highly robust, easily genetically modifiable, well-charac-
terized and phage infections-resistant organism for fer-
mentation [3]. However, in S. cerevisiae, the acetyl-CoA 
metabolism takes place in four different compartments, 
which hampers metabolic engineering for certain prod-
ucts. Acetyl-CoA functions as a precursor for several 
metabolic pathways in yeast. It is the end product of fatty 
acid β-oxidation, a precursor for energy generation, but 
at the same time, a substrate for fatty acid, isoprenoid, 
and amino acid biosynthesis. Therefore, acetyl-CoA is a 
favorable starting point for biotechnological applications 
which focus on production of lipids, polyketides, isopre-
noids, and alcohols [4].
Acetyl-CoA is present in the cytosol, mitochondria, 
nucleus, and peroxisomes in baker’s yeast. Cytosolic 
acetyl-CoA is produced via the pyruvate dehydrogenase 
(PDH)-bypass from pyruvate which first is converted into 
acetaldehyde via pyruvate decarboxylases. Acetaldehyde 
is then transformed into acetate mainly by acetaldehyde 
dehydrogenase Ald6, which uses NADPH as cofactor. 
Finally, acetate is converted into acetyl-CoA via ATP-
consuming acetyl-CoA synthetases (ACSs). However, 
acetaldehyde is mainly diverted to ethanol, which is the 
main reduction product in yeast. Also, the other precur-
sors of acetyl-CoA, pyruvate or acetate, can enter into 
one of the other mentioned compartments, and therefore 
less acetyl-CoA is available in cytosol [4]. Besides, there 
do not exist direct transport systems for acetyl-CoA 
between the compartments but only the glyoxylate cycle 
or carnitine/acetyl-carnitine shuttle [5].
Also, the Crabtree effect limits the availability of cyto-
solic acetyl-CoA. Most of glucose is converted into 
ethanol, even under aerobic conditions [6]. Another 
byproduct is glycerol, whose reduction pathway is also 
used for NAD+ regeneration to enable further glucose 
oxidation in glycolysis. To increase cytosolic acetyl-CoA 
levels for biotechnological purposes, several approaches 
have been undertaken. Alcohol dehydrogenase genes 
(ADH) were deleted to limit ethanol production; enzymes 
of the PDH-bypass were overexpressed [4]; ATP-inde-
pendent heterologous PDH complexes were expressed 
in the yeast cytosol [7]; or likewise, ATP-independent, 
heterologous pyruvate formate lyase was expressed [7, 
8]. Moreover, acetylating acetaldehyde dehydrogenases 
were tested, which convert acetaldehyde directly into 
acetyl-CoA without ATP consumption. The functionality 
of these enzymes in yeast was proven by overexpression 
in acs2 deletion mutants, as acs2 mutants are not able to 
grow on glucose without expressing another enzyme pro-
ducing acetyl-CoA in the cytosol [7].
A further promising enzyme is adhE from E.coli, which 
is a multifunctional oxidoreductase. This enzyme con-
sists of two domains, an acetaldehyde oxidoreductase 
and an ethanol oxidoreductase, and is probably an evolu-
tionary product of a gene fusion. A reason for this might 
be that catalytic sites are now closer together and one 
NADH binding site is shared [9]. In E.coli, adhE cata-
lyzes the reduction from acetyl-CoA into acetaldehyde 
and then into ethanol. However, Membrillo-Hernandez 
and coworkers were able to engineer the enzyme to pre-
fer the conversion of acetaldehyde into acetyl-CoA. For 
that, two point mutations were introduced: A267T and 
E568K. Mutation A267T was mainly responsible for 
the improved catalytic activity, and E568K stabilized 
the architectural integrity [9]. Thus, adhEA267T/E568K can 
function as an acetylating acetaldehyde dehydrogenase, 
as well.
Independent of the use of the endogenous PDH-bypass 
or heterologous enzyme for cytosolic acetyl-CoA pro-
duction, free CoA is also needed. Biosynthesis of CoA 
starts from pantothenate in yeast (Fig.  1). First, pan-
tothenate is converted into 4′-phosphopantothenate 
by pantothenate kinase Cab1. Together with cysteine, 
4′-phosphopantothenate is then transformed into 
4′-phosphopantothenoylcysteine, which is further con-
verted into 4′-phosphopantetheine, dephospho-CoA, 
and finally CoA [10]. The pantothenate kinase reaction is 
limiting CoA synthesis in yeast and is inhibited by acetyl-
CoA [10, 11]. Therefore, we used the overexpression of 
pantothenate kinase coaA from E.coli to increase CoA 
and n-butanol synthesis in yeast [2].
Additionally, in order to enhance CoA and finally 
acetyl-CoA production in the cytosol, increased sup-
ply of pantothenate in the growth medium is necessary 
[2]. Yeast cells can either take up pantothenate from the 
medium via the Fen2 transporter [12] or can synthesize 
it via an endogenous pathway starting from amino acids 
methionine and valine (Fig.  1). Valine is transaminated 
into 2-ketoisovalerate, which serves as a precursor for 
pantoate production. Pantoate in turn is transformed 
with β-alanine into pantothenate in an ATP-dependent 
reaction. The precursor of β-alanine is methionine, which 
is first converted to spermine [13]. The next step, the 
conversion of spermine into 3-aminopropanal via amine 
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oxidase Fms1, was found to be rate limiting for panto-
thenate synthesis [14]. Indeed, overexpression of FMS1 
even led to pantothenate excretion into the media. Fur-
ther on, 3-aminopropanal is transformed into β-alanine 
by aldehyde dehydrogenases Ald2/3, whereby Ald2 is 
mainly responsible for this reaction [13].
Heterologous n-butanol production via the acetoa-
cetyl-CoA-derived pathway in engineered yeasts needs 
high levels of acetyl-CoA [2, 6]. In this pathway, two mol-
ecules of acetyl-CoA are condensed to acetoacetyl-CoA. 
This reaction is catalyzed by endogenous yeast thiolase 
Erg10 [15]. Then, acetoacetyl-CoA can be reduced into 
3-hydroxybutyryl-CoA and further converted into cro-
tonyl-CoA via heterologous dehydrogenases and croto-
nases like hbd and crt from C. acetobutylicum [16]. For 
the irreversible conversion of crotonyl-CoA into butyryl-
CoA, trans-2-enoyl-CoA reductase ter of Treponema 
denticola was shown to be useful [6]. The last steps from 
butyryl-CoA into butyraldehyde and n-butanol can be 
catalyzed by aldehyde dehydrogenase eutE from E. coli 
[17] and/or aldehyde/alcohol dehydrogenase adhE2 from 
C. acetobutylicum [18]. Furthermore, on rich medium or 
via engineering of amino acid synthesis and degradation, 
S. cerevisiae is able to produce n-butanol also by endog-
enous amino acid-derived pathways (reviewed in [1]). In 
a recent study, the endogenous pathway of threonine was 
optimized and combined with an introduced citramalate 
synthase-mediated pathway, which enabled n-butanol 
production of 835  mg/L in complex medium under 
anaerobic conditions [19].
So far, with the contribution of only the acetoacetyl-
CoA-derived pathway in synthetic medium without 
addition of amino acids, metabolic engineering of S. cer-
evisiae resulted in n-butanol titers from 2.5 mg/L [20] up 
to 130  mg/L under anaerobic conditions [2]. Here, we 
report further improvements for n-butanol production 
with S. cerevisiae via an acetoacetyl-CoA-derived path-
way under aerobic conditions.
Fig. 1 Simplified metabolic pathway for CoA biosynthesis in Saccharomyces cerevisiae. Shown are the relevant steps in yeast’s metabolism for 
endogenous synthesis of free CoA. The precursor pantothenate can be taken from medium via transporter Fen2 or can be synthesized endog-
enously from amino acids
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Methods
Strains and media
Yeast strains used in this study are listed in Table  1. 
Media composition was as described in [2]. Ethanol con-
centration in liquid and solid media was 2% (v/v). For 
cross-feeding assays on solid synthetic complete medium 
(SCD) lacking pantothenate, 1.7  g/L yeast nitrogen 
base without pantothenate (YNB-Calcium pantothen-
ate) was used from the company Sunrise Science Prod-
ucts, San Diego, CA 92131. Moreover, SCD medium 
contained 5  g/L ammonium sulfate, amino acid supple-
ments, as well as 7.5 g/L agar for soft agar (standard agar 
with 20 g/L) and was adjusted to pH 6.3 with potassium 
hydroxide.
Plasmid and strain construction
Assembly of vectors and constructions of VSY0 (Δadh1–5) 
and VSY10 were described in [2], and important metabolic 
routes are shown in Additional file 1: Figure S1. All genes 
were codon-optimized according to the yeast glycolytic 
codon usage [21], except for ScALD2 and ScPAN6, which 
were amplified from chromosomal DNA. Strains VSY4, 
5, and 7 were established in order to evolve and compare 
strains with Δacs1 or/and Δacs2 deletion carrying Ecad-
hEA267T/E568K (Table  1). Therefore, EcadhEA267T/E568K with 
promoter pPFK1 and terminator tDIT1 was integrated via 
homologous recombination with 400  bp overlaps into the 
respective gene locus on YEPD or YEPE in corresponding 
BY strains (Y06868 and JDY2). Acetylating acetaldehyde 
dehydrogenase was introduced in the already deleted ACS2 
locus of JDY2, and then ACS1 was deleted with kanMX 
deletion cassette. Resulting VSY7 was grown aerobically in 
30 mL YEPD with a starting OD600 of 0.3 for 8 days until 
an OD600 of 2 was reached. In a next round under the same 
conditions, an OD600 of 2 was reached already after 1 day 
(VSY7_evolved). Sequencing of EcadhEA267T/E568K locus of 
one single clone revealed a new mutation, and EcadhEA267T/
E568K/R577S was amplified from chromosomal DNA in order 
to introduce it in VSY7. The resulting strain was named 
VSY7_R577S.
In VSY10 EcadhEA267T/E568K was exchanged against 
EcadhEA267T/E568K/R577S, which resulted in VSY13. Further-
more, the native promoter of FMS1 (300  bp upstream) 
was exchanged against the strong glycolytic promoter 
pADH1 with the aid of HIS3 marker. Fragments contain-
ing 400 bp homologous region, HIS3 sequence, pADH1, 
and 400 bp homologous region of FMS1 were assembled 
via fusion PCR [22] in order to integrate the cassette into 
VSY13, resulting in VSY15. For further deletion of ALD6 
in VSY15, CrisprCas method was used [23] (crRNA 
was generated by www.dna20.com), resulting in VSY19. 
Genome integrations and deletions were confirmed by 
PCR analysis. All primers and used donors for CrisprCas 
system are shown in Additional file 1: Table S1 and pro-
moters and terminators of cloned genes in Additional 
file 1: Table S2.
Fermentations for n‑butanol production
All fermentation conditions, as well as HPLC measure-
ments, were described in [2]. One difference was that fer-
mentations were carried out aerobically in 30  mL SMD 
media and not semi-anaerobically and that additionally, 
potassium acetate was used as a standard for HPLC with 
concentrations of 0.5–20 g/L.
Growth assays and cross‑feeding tests
For growth assays on solid media, cultures were grown to 
exponential phase, washed, and adjusted to an OD600 of 
1. Three tenfold serial dilutions were prepared, and 5 µl 
of each solution was spotted on YEPD, YEPE, or SCD 
agar plates and incubated at 30  °C under aerobic condi-
tions. For cross-feeding tests on solid media [14], 10  µl 
of overnight cultures of Δfms1 or Δpan6 were added to 
SCD agar without pantothenate.
Enzyme assay
For enzyme assays, Δadh1–5 (VSY0) was transformed 
with respective vector (pRS41H, pVS4, pVS4ev) and incu-
bated overnight in 50 mL YEPD to an OD of OD600 0.8–
1. Further preparation and implementation of enzyme 
assays were conducted as described in [2].
For dehydrogenase activity of the acetylating acetal-
dehyde dehydrogenase (adhEA267T/E568K), the reaction 
buffer contained 50  mM CHES and 0.2  mM DTT with 
pH 9.5. The increase of NADH concentrations was moni-
tored at 340 nm. The acetaldehyde dehydrogenase activ-
ity was measured with 20 mM acetaldehyde as substrate 
and 0.8  mM NAD+ and 0.1  mM CoA as cofactors. The 
reaction was started by the addition of cooled acetalde-
hyde (based on [7]). Stability assay was performed by 
preparing aliquots of cell extract, that were kept on ice 
until incubation at 30° in a thermo block. Dehydrogenase 
activity assay was directly performed after incubation for 
0–40 min at 30° (based on [9]).
Results and discussion
Aerobic conditions improve n‑butanol production 
in engineered n‑butanol‑producing S. cerevisiae
In our previous work [2] we had constructed a yeast strain 
engineered with an acetoacetyl-CoA-derived n-butanol 
production pathway and optimized for enhanced CoA 
and acetyl-CoA synthesis, strain VSY10. Fermentations 
with this strain were performed under semi-anaerobic 
oxygen-limited conditions and resulted in n-butanol 
titers up to 130 mg/L and yields up to 0.012 g/g glucose. 
Nevertheless, VSY10 was not able to consume more than 
Page 5 of 11Schadeweg and Boles  Biotechnol Biofuels  (2016) 9:257 
Table 1 Yeast strains and plasmids used in this study
Genes from Sc, Saccharomyces cerevisiae; Ca, Clostridium acetobutylicum; Ec, E.coli; Td, Treponema denticola; Sp, Streptococcus pneumoniae are indicated by prefixes in 
superscript. Promoters are indicated in Additional file 1: Table S2. kanMX G418 resistance, hphNT1 hygromycin resistance, Ampr ampicillin resistance
Strain or plasmid Characteristics Reference
Strains
 VSY0 MATa; ura3-52; trp1-289; leu2-3_112; his3Δ1; MAL2-8C; SUC2
adh1::loxP adh3::loxP adh5::loxP adh4Δ::loxP adh2Δ::LEU2
[2]
 Y00000 BY4741 MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0 Euroscarf,
Frankfurt
 Y00595 BY4741 Mata; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0; fms1::kanMX4 Euroscarf,
Frankfurt








 JDY2 MATα; his3Δ1; leu2Δ0; lys2Δ0; MET15; ura3Δ0; acs2::kanMX4 Lab stocks,
Boles group
 VSY4 MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0; acs1::kanMX4 sfa1Δ:
EcadhE A267T/E568K/hphNT1
This work
 VSY5 MATα; his3Δ1; leu2Δ0; lys2Δ0; MET15; ura3Δ0; acs2::kanMX4;
sfa1Δ: EcadhE A267T/E568K, hphNT1
This work
 VSY7 MATα; his3Δ1; leu2Δ0; lys2Δ0; MET15; ura3Δ0; acs2Δ:EcadhE
A267T/E568K, hphNT1; acs1::kanMX4
This work
 VSY7_evolved MATα; his3Δ1; leu2Δ0; lys2Δ0; MET15; ura3Δ0; acs2Δ:EcadhE A267T/E568K/R577S, hphNT1; acs1::kanMX4 with unknown 
mutations for growth on glucose
This work
 VSY7_R577S MATα; his3Δ1; leu2Δ0; lys2Δ0; MET15; ura3Δ0; acs2Δ:EcadhE
A267T/E568K/R577S, hphNT1; acs1::kanMX4
This work
 VSY10 MATa; ura3-52; trp1-289; leu2-3_112; his3Δ1; MAL2-8C; SUC2
adh1::loxP; adh3::loxP: adh5::loxP; adh4Δ::loxP; adh2Δ::LEU2; sfa1Δ: EcadhE A267T/E568K, hphNT1; adh6Δ: EccoaA, natNT2; 
gpd2Δ: ScERG10, Cahbd, Cacrt, Tdter, CaadhE2, EceutE, kanMX
[2]
 VSY13 MATa; ura3-52; trp1-289; leu2-3_112; his3 Δ1; MAL2-8C; SUC2
adh1::loxP; adh3::loxP; adh5::loxP; adh4Δ::loxP; adh2Δ::LEU2; adh6Δ: EccoaA, loxP; sfa1Δ: EcadhE A267T/E568K/R577S, loxP; 
gpd2Δ: ScERG10, Cahbd, Cacrt, Tdter, CaadhE2, EceutE, kanMX
This work
 VSY15 MATa; ura3-52; trp1-289; leu2-3_112; his3 Δ1; MAL2-8C; SUC2
adh1::loxP; adh3::loxP; adh5::loxP; adh4Δ::loxP; adh2Δ::LEU2; adh6Δ: EccoaA, loxP; sfa1Δ: EcadhE A267T/E568K/R577S, loxP; 
pFMS1Δ::HIS3, pADH1; gpd2Δ: ScERG10, Cahbd, Cacrt, Tdter, CaadhE2, EceutE, kanMX
This work
 VSY19 MATa; ura3-52; trp1-289; leu2-3_112; his3 Δ1; MAL2-8C; SUC2
adh1::loxP; adh3::loxP; adh5::loxP; adh4Δ::loxP; adh2Δ::LEU2; adh6Δ:: coaA, loxP; sfa1Δ:: adhE A267T/E568K/R577S, loxP; 
pFMS1Δ::HIS3, pADH1; ald6Δ; gpd2Δ: ScERG10, Cahbd, Cacrt, Tdter, CaadhE2, EceutE, kanMX
This work
Plasmids
 pRS41H CEN6ARS4, hphNT1, Ampr [29]
 pRS62H 2µ, hphNT1, Ampr, shortened HXT7 promoter and CYC1
terminator
[30]
 pVS4 CEN6ARS4, hphNT1, Ampr, EcadhE A267T/E568K [2]
 pVS4ev CEN6ARS4, hphNT1, Ampr, EcadhE A267T/E568K/R577S This work
 pRCC-K_ALD6 2µ, kanMX, Ampr, pROX3_Cas9_tCYC1, gRNA for ALD6 This work
 pRS62H_ERG10 2µ, hphNT1, Ampr, ScERG10 This work
 pRS62H_hbd 2µ, hphNT1, Ampr, Cahbd This work
 pRS62H_crt 2µ, hphNT1, Ampr, Cacrt This work
 pRS62H_ter 2µ, hphNT1, Ampr, Tdter This work
 pRS62H_adhE2 2µ, hphNT1, Ampr, CaadhE2 This work
 pRS62H_eutE 2µ, hphNT1, Ampr, EceutE This work
 pRS41H_pTPI1_
NOX
CEN6ARS4, hphNT1, Ampr, NADHoxidase SpNOX Lab stocks,
Boles group
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about half of the glucose. This might be due to inefficient 
NADH re-oxidation under the anaerobic conditions as 
ethanol and glycerol production were nearly eliminated 
in the strain and the introduced n-butanol pathway was 
obviously not yet strong enough to compensate these 
deficiencies.
Under aerobic conditions, cytosolic NADH can be re-
oxidized also by external mitochondrial NADH dehydro-
genases or by mitochondrial redox shuttle mechanisms 
[24]. Therefore, we repeated the fermentations with 
VSY10 now under more aerobic conditions with shake 
flask cultures. The fermentations were performed in 
SMD media supplemented with additional 25 µM panto-
thenate to enhance CoA synthesis [2].
Indeed, glucose consumption of VSY10 was improved 
under aerobic conditions (Additional file  1: Figure S2a), 
and n-butanol titers increased up to 235 mg/L (Table 2). 
Moreover, growth was improved to final OD600 values 
of more than 2 (Additional file  1: Figure S2b), whereas 
under anaerobic conditions, OD600 values did not exceed 
1.8. Ethanol production did not change substantially 
(Additional file  1: Figure S3). Nevertheless, due to the 
higher glucose consumption, n-butanol yields were only 
slightly increased under aerobic conditions (Table 2) and 
reached 0.013 g/g glucose.
A R577S mutation in adhE increases acetyl‑CoA supply 
and further improves n‑butanol production
In VSY10, ATP-independent acetyl-CoA synthesis had 
been increased via introduction of an acetylating acet-
aldehyde dehydrogenase mutant enzyme from E. coli, 
adhEA267T/E568K [2]. This mutant adhE form favors the 
conversion of acetaldehyde to acetyl-CoA instead of con-
verting acetyl-CoA to ethanol (Additional file  1: Figure 
S4) [9] but only if enough free CoA is available [2]. Nev-
ertheless, the acetyl-CoA-forming activity of adhEA267T/
E568K seemed to be quite low in S. cerevisiae.
To further improve adhEA267T/E568K activity, strain 
VSY7 (Δacs1/2, adhEA267T/E568K) was constructed which 
due to the deletion of both acetyl-CoA synthase genes, 
ACS1 and ACS2, is completely dependent on adhE-
mediated cytosolic acetyl-CoA production. Growth of 
this strain on YEPD medium was very slow but increased 
rapidly already after some days of incubation (see “Meth-
ods” section), indicating the occurrence of spontaneous 
mutations improving acetyl-CoA production. The adhE 
gene of a single clone (VSY7_evolved) was amplified and 
sequenced, revealing a mutation at position 1731 of the 
adhE coding sequence changing amino acid R577 to S. As 
this residue is close to mutation E568K in the ethanol oxi-
doreductase domain of adhEA267T/E568K, it was probably 
involved in the better growth of strain VSY7. To test this, 
strain VSY7_R577S was constructed by directly replacing 
the adhEA267T/E568K double-mutation allele of strain VSY7 
with the adhEA267T/E568K/R577S triple-mutation allele. 
Growth was compared to the wild-type strain BY4741, 
the evolved VSY7 as well as VSY4 and VSY5 (Fig.  2). 
VSY4 is deleted for ACS1 but still contains the constitu-
tively expressed ACS2, whereas VSY5 only contains the 
glucose-repressed ACS1, and both contain the adhEA267T/
E568K double-mutation allele. As expected, VSY4 could 
grow normally with glucose or ethanol and VSY5 could 
grow normally with ethanol. VSY5 and VSY7 exhibited 
only very weak growth on glucose. The adhEA267T/E568K/
R577S triple-mutation allele clearly improved the growth 
of VSY7_R577S on glucose and ethanol, as compared to 
VSY7. Nevertheless, the original VSY7_evolved strain 
grew even better indicating the presence of still other 
mutations promoting the production of acetyl-CoA.
To directly measure the influence of the R577S muta-
tion on the performance of adhE, the enzyme activity 
and stability were tested in vitro. As the enzyme activity 
assay is based on the oxidation of acetaldehyde and the 
concomitant production of NADH, a Δadh1–5 alco-
hol dehydrogenase-deficient yeast mutant strain had to 
be used to avoid the re-oxidation of produced NADH 
by endogenous alcohol dehydrogenases. Plasmids pVS4 
(adhEA267T/E568K), pVS4ev (adhEA267T/E568K/R577S), and 
Table 2 n-Butanol titers and yields of n-butanol producing 
strains
Titers and yields of anaerobic [1] and aerobic fermentations in SMD with or 
without addition of 25 µM pantothenate and with or without additional pVS4ev 
or pRS62H_tdTer vector are shown for strains VSY10 (Δadh1–6 sfa1 gpd2, with 
n-butanol pathway genes, coaA and adhEA267T/E568K), VSY13 (like VSY10, but 
adhEA267T/E568K/R577S instead of adhEA267T/E568K), VSY15 (VSY13 with pADH1_FMS1) 
and VSY19 (VSY15 with Δald6). The maximal titers in fermentations are shown, 
which is for VSY10 and VSY15/VSY19 + pRS62H_tdTer after 74 h and VSY19 
strains after 50 h and for all other strains after 100 h. Yields are always calculated 
with values referring to samples taken after 74 or 50 h. The mean values of three 
independent replicates are shown with standard deviations
Strain n‑Butanol
Titer [mg/L] Yield [g/g glucose]
Anaerobic
 VSY10 108.08 ± 10.8 0.010 ± 0.0003
 VSY10 + 25 µM pantothenate 130.46 ± 19.7 0.012 ± 0.0008
Aerobic
 VSY10 148.21 ± 14.08 0.012 ± 0.0005
 VSY10 + 25 µM pantothenate 235.02 ± 7.74 0.013 ± 0.0005
 VSY13 165.00 ± 15.42 0.010 ± 0.0017
 VSY13 + 25 µM pantothenate 247.34 ± 8.23 0.015 ± 0.0006
 VSY15 243.20 ± 14.13 0.016 ± 0.0017
 VSY15 + pVS4ev 254.49 ± 5.89 0.017 ± 0.0001
 VSY15 + pRS62H_tdTer 448.72 ± 3.16 0.028 ± 0.0010
 VSY19 633.92 ± 19.33 0.057 ± 0.002
 VSY19 + pVS4ev 643.31 ± 17.42 0.047 ± 0.0007
 VSY19 + pRS62H_tdTer 859.05 ± 120.32 0.071 ± 0.006
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the empty vector pRS41H were transformed into strain 
VSY0 (Δadh1–5), and crude extracts were prepared. 
AdhEA267T/E568K exhibited a specific activity of 12.7 mU/
mg protein, whereas adhEA267T/E568K/R577S of 22.2 mU/mg, 
indicating that indeed the R577S mutation improved the 
conversion of acetaldehyde to acetyl-CoA. As Membrillo-
Hernandez and coworkers [9] had found that the second 
mutation E568K mainly stabilizes the adhEA267T single 
mutant form, a stability assay was performed. For that, 
cell extracts were incubated at 30  °C for different time 
periods up to 40  min. However, acetaldehyde dehydro-
genase activity decreased for both, adhEA267T/E568K and 
adhEA267T/E568K/R577S (Additional file  1: Figure S5), indi-
cating that the R577S mutation does not further stabilize 
the mutant adhE.
To test the effect of the adhEA267T/E568K/R577S triple-
mutation allele on n-butanol production, strain VSY13 
was constructed which is identical to VSY10 but has the 
adhEA267T/E568K/R577S triple-mutation allele instead of the 
adhEA267T/E568K double-mutation allele. In aerobic shake 
flask cultivation in SMD media with 25  µM pantothen-
ate VSY13 produced slightly more n-butanol (247 mg/L) 
than VSY10 (Table 2). The increase was strictly depend-
ent on the addition of pantothenate (Additional file 1: Fig-
ure S6). Also the n-butanol yield of VSY13 was increased 
to 0.015  g/g glucose (Table  2). The results indicate that 
the R577S mutation in adhEA267T/E568K/R577S enables even 
more efficient flux from acetaldehyde to acetyl-CoA, 
especially in the presence of pantothenate providing 
more CoA [1], which is needed as the co-substrate of the 
mutant adhE form (Additional file 1: Figure S6).
Enhancement of endogenous pantothenate synthesis 
for n‑butanol production
We had shown before that overexpression of pantothen-
ate kinase coaA and addition of pantothenate increased 
n-butanol production due to an increased supply of CoA 
[2]. However, pantothenate is expensive and its addition 
is not economical under industrial conditions. Therefore, 
we reasoned to improve its endogenous production. Pan-
tothenate is synthesized by condensation of β-alanine 
and pantoate (Fig.  1). β-Alanine is derived from sper-
mine via Fms1 and Ald2/3, whereas pantoate is derived 
from 2-ketoisovalerate via Ecm31 and Pan5. White and 
coworkers [14] have shown that overexpression of amine 
oxidase Fms1 leads to overproduction of pantothenate 
and its secretion into the medium, indicating Fms1 as a 
limiting step in the pathway. To test whether this is true 
also for our strains, the native promoter of FMS1 was 
replaced by the strong ADH1 promoter in the genome of 
VSY13, resulting in strain VSY15. A spotting assay was 
performed with Δfms1 pantothenate auxotrophic cells, 
which were included in SCD agar medium without pan-
tothenate (Fig. 3). Whereas VSY13 cells did not support 
the growth of the Δfms1 cells, halos of growing Δfms1 
cells could be observed surrounding the spots with 
VSY15 cells. This indicated that in contrast to VSY13, 
the VSY15 cells overproduce and even secrete a com-
pound that can complement the pantothenate auxotro-
phy downstream of Fms1. As also Δecm31 mutant cells 
[14] and Δpan6 cells (data not shown) could be comple-
mented by spots of FMS1 overexpressing cells, it is likely 
that the secreted compound is pantothenate. Secretion 
of pantothenate by VSY15 was a little bit surprising as 
VSY15 overexpresses pantothenate kinase coaA. There-
fore, the results indicate that this reaction or a reaction 
further downstream in the CoA pathway is still limiting 
CoA synthesis. Nevertheless, the results demonstrate 
that the overexpression of FMS1 resulted in overproduc-
tion of pantothenate. On the other hand, overexpres-
sion of ALD2 and/or PAN6 did not lead to the secretion 








Fig. 2 Spotting assay of adhEA267T/E568K/R577S strains. Cells were grown to exponential phase and adjusted to an OD600 of 1. Tenfold serial dilutions 
were spotted onto YEPD or YEPE under aerobic conditions and incubated at 30 °C for 3 days. As a control, wild-type BY4741 (Y00000) was used
Page 8 of 11Schadeweg and Boles  Biotechnol Biofuels  (2016) 9:257 
diameter of Δfms1 cell halos in combination with FMS1 
overexpression (data not shown).
In order to test the effect of endogenous pantothen-
ate overproduction on n-butanol formation, aerobic 
fermentations were performed with VSY15 in SMD 
medium without pantothenate. A significantly higher 
n-butanol titer was produced by VSY15 (243  mg/L) 
compared to its progenitor VSY13 (165 mg/L) (Table 2). 
Interestingly, the n-butanol titer produced by VSY15 in 
the absence of pantothenate was nearly exactly the same 
as the titer of VSY13 in the presence of additional pan-
thothenate (247 mg/L), indicating that overexpression of 
FMS1 can completely replace the addition of exogenous 
pantothenate.
The trans‑2‑enoyl‑CoA reductase (ter) reaction is a 
bottleneck in the acetoacetyl‑CoA‑derived n‑butanol 
pathway
An additional copy of adhEA267T/E568K/R577S by transfor-
mation of VSY15 with plasmid pVS4ev only marginally 
increased n-butanol production (254  mg/L) (Table  2). 
Therefore, it was reasonable to test whether a bottleneck 
in the heterologous n-butanol synthesis pathway might 
limit n-butanol production. To test this, all the genes of 
the n-butanol pathway were individually overexpressed 
from multi-copy vectors in strain VSY15 in addition to 
the genomic copies. The genes ScERG10, Cahbd, Cacrt, 
Tdter, EceutE, and CaadhE2 were each cloned on a high 
copy vector (pRS62H) behind the strong HXT7 promoter 
fragment, transformed into VSY15, and aerobic fermen-
tations were performed in SMD medium with hygromy-
cine. The control strain with the empty vector reached 
n-butanol titers of 223 mg/L (Fig. 4). Strains overexpress-
ing ERG10, hbd, crt, or eutE reached similar levels. Over-
expression of CaadhE2 had a negative effect on growth 
and n-butanol production. Interestingly, overexpression 
of Tdter had a positive effect on n-butanol production 
(Fig. 4) and the n-butanol titer, and the yield increased up 
to 449 mg/L and 0.028 g/g glucose, respectively (Table 2). 
These results indicate that the reduction of crotonyl-CoA 
into butyryl-CoA by ter is a limiting step in the path-
way. They are consistent with the low enzyme activities 
of ter in yeast [2] and the secretion of crotonal, probably 
derived from crotonyl-CoA, as observed by Swidah and 
coworkers [25].
A block in the reductive part of n-butanol produc-
tion might lead to inefficient NADH re-oxidation and 
therefore an insufficient supply of NAD+ for glycolysis 
and the acetylating adhE. Therefore, we tested whether 
expression of a water-forming soluble oxygen-depend-
ent NADH oxidase (nox) from Streptococcus pneu-
moniae [26] might be beneficial for growth, glucose 
consumption, and product formation. For this, VSY15 
was transformed with the low copy plasmid pRS41H-
pTPI1_NOX, which carries a codon-optimized version of 
nox expressed behind the strong TPI1 promoter and as a 
control with the empty vector pRS41H. Indeed, in aero-
bic fermentations, growth and glucose consumption was 
increased especially in the beginning of the fermentation 
(Additional file  1: Figure S7). However, n-butanol pro-
duction was significantly reduced (89 mg/L compared to 
225 mg/L). These results indicate that the availability of 
NAD+ might be important for the growth performance 
of the cells, but that high levels of NADH are needed as 
a driving force for the n-butanol production. Obviously, 
the expression level of NADH oxidase would need to be 
adjusted very precisely in order to balance the optimal 
NAD+/NADH ratios.
Deletion of acetaldehyde dehydrogenase ALD6 gene 
further improves n‑butanol production
In VSY15, acetaldehyde can be converted to acetyl-CoA 
either via the adhEA267T/E568K/R577S or via acetaldehyde 
dehydrogenases (mainly Ald6) followed by Acs1/2 acetyl-
CoA synthetases. In the Ald6-dependent pathway, ace-
tate is an intermediate, and can be lost out of the cells. 
Moreover, adhE produces NADH, while Ald6 produces 
NADPH. As the n-butanol pathway is strictly dependent 
on NADH, the adhE pathway should be more favorable 
for n-butanol production. S. cerevisiae does not contain 
transhydrogenases, and therefore NADPH and NADH 
cannot be converted into one another [27]. However, in 
VSY15, adhE has to compete with Ald6 for the substrate 
acetaldehyde. Also, the Ald6-dependent pathway is ener-
getically more costly because acetyl-CoA synthetases 
VSY13
VSY15
Fig. 3 Spotting assay of pADH1_FMS1 strains on SCD without pan-
tothenate, containing Δfms1 cells. Cells were grown to exponential 
phase and adjusted to an OD600 of 1. Tenfold serial dilutions were 
spotted onto SCD lacking pantothenate, whereby 10 µl of Δfms1 
overnight culture was added to the medium. Control VSY13 (Δadh1–6 
sfa1 gpd2, n-butanol pathway genes, coaA and adhEA267T/E568K/R577S) 
and VSY15 (VSY13 with pADH1_FMS1) were compared. Cells were 
incubated aerobically at 30 °C for 4 days
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hydrolyze ATP to AMP and pyrophosphate, whereas 
adhE does not use ATP.
To strengthen the adhE pathway, we deleted ALD6 
in strain VSY15, resulting in VSY19, and performed 
aerobic fermentations in SMD medium  (Fig.  5). 
Indeed, n-butanol production increased remarkably 
from 243  mg/L (strain VSY15) to 634  mg/L with strain 
VSY19 (Table  2). The n-butanol yield increased from 
0.016 to 0.057  g/g glucose. The deletion of ALD6 was 
also reflected in lower acetate production (432  mg/L in 
VSY15 and 178  mg/L in VSY19). An additional copy of 
adhEA267T/E568K/R577S by transformation of VSY19 with 
plasmid pVS4ev only marginally increased n-butanol 
production (643  mg/L) (Table  2). However, additional 
overexpression of ter by transformation of VSY19 with 
plasmid pRS62H_tdTer further increased the n-butanol 
titer to 859 mg/L and the yield to 0.071 g/g glucose. The 
results show that adhEA267T/E568K/R577S can convert acetal-
dehyde more efficiently into acetyl-CoA if the competing 
NADP+- and ATP-dependent pathway are blocked. This 
prevents the leakage of acetate and favors formation of 
NADH as a driving force for n-butanol production.
Conclusion
One of the major problems in n-butanol production 
with yeast seems to keep an optimal redox balance of 
the cofactor NAD between its oxidized form, NAD+, 
and the reduced form, NADH. Glycolysis is very fast in 
yeast, and therefore there is a high need for NAD+. On 
the other hand, the driving force for high production 
rates of n-butanol is NADH [16]. But, obviously flux 
through the n-butanol pathway in yeast is not yet high 
enough to provide enough NAD+ for the continuation 
of glycolysis. This finally results in a slowdown of glucose 




















Fig. 4 n-Butanol concentrations of n-butanol-producing yeast strains additionally overexpressing enzymes of the n-butanol biosynthesis pathway. 
Shown are maximum n-butanol titers (Cahbd and Tdter after 74 h and others after 100 h) of aerobic fermentations in SMD media. Bottleneck analysis 
was carried out with VSY15 (Δadh1-6 sfa1 gpd2 with n-butanol pathway genes, coaA and adhEA267T/E568K/R577S, pADH1_FMS1) overexpressing pRS62H 
(high copy vector, promoter pHXT7, terminator tFBA1) with one each enzyme of n-butanol pathway. As a control, empty vector pRS62H was used. 
Genes from Sc: Saccharomyces cerevisiae, Ca: Clostridium acetobutylicum, Ec: E.coli, and Td: Treponema denticola are indicated by prefixes in super-
script. Error bars represent the standard deviation of three independent replicates
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consumption. Expression of nox could in fact partially 
alleviate glucose consumption by increasing NADH 
re-oxidation, but then obviously NADH was lacking as 
driving force for n-butanol production. In contrast, the 
aerobic conditions employed in this work, probably by 
allowing some NAD+ regeneration, had a positive effect 
on both glucose consumption and n-butanol forma-
tion. Moreover, blocking NADPH formation by deletion 
of ALD6 in favor of NADH formation via adhE strongly 
improved n-butanol production. On the other hand, 
provision of an excess supply of NADH using the more 
reduced sugar alcohol sorbitol as the carbon source after 
overexpression of a sorbitol dehydrogenase and a sorbi-
tol transporter [28] in the n-butanol-producing strain 
VSY19 had a detrimental effect on growth, sorbitol con-
sumption, and butanol production (data not shown) in 
contrast to the fast growth and sorbitol consumption of a 
wild-type ethanol-producing yeast strain [28].
The limiting step in the n-butanol pathway seems to be 
the ter reaction. Indeed, this was already indicated by the 
work of Swidah and coworkers [25] who observed cro-
tonal secretion in n-butanol-producing yeasts. Therefore, 
there is a high need to optimize the conversion of croto-
nyl-CoA to butyryl-CoA for improved n-butanol produc-
tion with yeast.
The other driving force for n-butanol production is 
acetyl-CoA. In this work, we could further improve its 
synthesis by providing more substrate in the form of 
CoA via endogenous overproduction of pantothenate. 
Moreover, we found an improved version of acetylating 
acetaldehyde dehydrogenase adhE, adhEA267T/E568K/R577S. 
Nevertheless, although the pantothenate kinase reac-
tion was already improved, there still seems to be a bot-
tleneck in the CoA biosynthesis pathway as pantothenate 
was even secreted out of the cells. Moreover, as indicated 
by the poor complementation of acs mutants, also adhE 
seems to be not yet working optimally.
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Fig. 5 n-Butanol production of VSY15 and VSY19 with or w/o additional overexpression of ter. n-Butanol titers are shown of VSY15 (Δadh1–6 sfa1 
gpd2 with n-butanol pathway genes, coaA, adhEA267T/E568K/R577S, pADH1_FMS1) and VSY19 (VSY15 with Δald6) with or without pRS62H_tdTer. Error 
bars represent the standard deviation of three independent replicates
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